1) Human Epidermal-growth-factor Receptor 4(HER4)
人体表皮生长因子受体4
2) human epidermal growth factor receptor 2
人表皮生长因子受体2
1.
Objective To detect the expressions of human epidermal growth factor receptor 2 (Her-2), epidermal growth factor receptor (EGFR), presenilin 2 (PS-2) and estrogen receptor (ER) in breast cancer and discuss their clinical implications.
目的探讨人表皮生长因子受体2(Her-2)、表皮生长因子受体(EGFR)、雌激素调节蛋白(PS-2)、雌激素受体(ER) 在乳腺癌中的表达及其临床意义。
3) HER2 mRNA
人表皮生长因子受体2mRNA
4) human epidermal receptor 2
人表皮生长因子受体2
1.
Objective To investigate the relationship between the survival time and the high-expression of epidermal growth factor receptor (EGFR) and human epidermal receptor 2 (HER2) in breast cancer patients, and assess the feasibility of using the two markers either alone or in combination for predicting the prognosis of the patients.
目的研究乳腺癌人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)高表达与生存期的关系,探讨其单独或联合作为预后指标的可行性。
6) human epithelial growth factor receptor-2
人表皮生长因子受体-2
1.
Objective: To identify molecular markers epithelial growth factor receptor(EGFR) and human epithelial growth factor receptor-2(HER2) to predict the sensitivity of chemoradiotherapy(CRT)in the esophageal squamous cell carcinoma(ESCC).
目的:研究分子标记物表皮生长因子受体(EGFR)、人表皮生长因子受体-2(HER2)预测食管鳞状细胞癌同步放化疗敏感性的价值。
补充资料：表皮生长因子受体
表皮生长因子受体
为膜受体酪氨酸激酶，因其上有受体分子而表现酶的活性。对其形成的调节机制尚不清楚。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条